HCPCS Level IIsuppliesActive
A9543
Y90 ibritumomab, rx
BETOS: I1E
Effective: 2025-01-01
Referenced in 2 policies
Description
Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries
Medicare Fee Schedule
2026 Medicare Physician Fee Schedule national payment rates
$0.00
Non-Facility Price
$0.00
Facility Price
0.00
Work RVU
0.00
Total RVU (Non-Fac)
XXX
Global Days
Carrier Priced
Status